The increase of plasminogen activator inhibitor activity is associated with graft occlusion in patients undergoing aorto-coronary bypass surgery

British Journal of Haematology

Volumn 99, Issue 2, 1997, Pages 262-267

  Rifon J ^a   Paramo J A ^a,b   Panizo, C ^a   Montes, R ^b   Rocha, E ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Aortocoronary bypass; Fibrinolysis; PAI 1; Thrombosis

Indexed keywords

FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FIBRINOLYSIS; GRAFT OCCLUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMINOGEN ACTIVATION; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THROMBOSIS;

EID: 0030664330     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.3913205.x     Document Type: Article

References (35)

1. Arnessen, H., Semb, G., Hol, R. & Karlsen, H. (1983) Fibrinolytic capacity after venous stasis in patients undergoing aorto-coronary bypass surgery: relation to shunt occlusion. Scandinavian Journal of Haematology, 30, (Suppl. 39), 43-46.
2. Aznar, J., Estellés, A., Tormo, G., Sapena, P., Blanch, S. & España, F. (1988) Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease. British Heart Journal, 59, 535-541.
3. Barboriak, J.J., Pintar, K., Van Horn, D.L., Ratayias, G.E. & Korus, M.E. (1978) Pathologic findings in the aortocoronary vein grafts: a scanning electron microscopy study. Atherosclerosis, 29, 69-80.
4. Chesebro, J.H., Lam, J.Y.T. & Fuster, V. (1986) The pathogenesis and prevention of aorto-coronary vien bypass graft occlusion and restenosis after arterial angioplasty: role of vascular injury and platelet thrombus deposition. Journal of the American College of Cardiology 8, 58b-66b.
5. Chmielewska, J., Ranby, M. & Wiman, B. (1983) Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thrombosis Research, 31, 427-436.
6. Clauss, A. (1957) Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematologica, 17, 237-246.
7. Collen, D. & Lijnen, H.R. (1991) Basic and clinical aspects of librinolysis and thrombolysis. Blood, 78, 3114-3124.
8. D'Angelo, A., Kluft, C., Verheijen, J.H., Rijken. D.C., Mozzi, E. & Mannucci, P.M. (1985) Fibrinolytic shut-down after surgery: impairment of the balance between tissue-type plasmicogen activator and its specific inhibitor. European Journal of Clinical Investigation, 15, 308-312.
9. Declerck, P.J., Alessi, M.C., Verstraete, M., Kruithof, E. X. R., Juhan-Vague, I. & Collen, D. (1988) Measurement, of plasminogen activator inhibitor 1 in biological fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood, 71, 220-225.
10. Engesser, L., Brommer, E.J.P., Kluft, C. & Briët, E. (1989) Elevated plasminogen activator inhibitor (PAI), a cause of thrombophilia? A study in 203 patients with familial or sporadic venous thrombophilia. Thrombosis and Haemostasis, 62, 673-680.
11. Falk, E. (1989) Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. American Journal of Cardiology, 63, 114E-120E.
12. Fujii, S., Sawa, H., Safitz, J.E., Lucore, C.L. & Sobel, B.E. (1992) Induction of endothelial cell expression of the plasminogen activator inhibitor type 1 gene by thrombosis in vivo. Circulation, 86, 2000-2010.
13. Fuster, V. Badimon, L., Badimon, J.J. & Chesebro, J.H. (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes (second of two parts). New England Journal of Medicine, 326, 310-318.
14. Fuster, V. & Chesebro, J.H. (1986) Role of platelets and platelet inhibitors in aorto-coronary artery vein graft disease. Circulation, 75, 227-232.
15. Hamsten, A. (1993) The hemostatic system and coronary heart disease. Thrombosis Research, 70, 1-38.
16. Hamsten, A., Wiman, B., De Faire, V. &. Blombäck, H. (1985) Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. New England Journal of Medicine, 313, 1557-1563.
17. Hoff, H.F., Beck, G.J., Skibinski, C.I., Jurgens, G., O'Neil, J., Kramer, J. & Lytle, B. (1990) Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation, 82, 1046-1048.
18. Hutchings, G.M. (1980) Pathological changes in aortocoronary bypass grafts. Annual Review of Medicine, 31, 289-301.
19. Juhan-Vague, I., Roul, C., Alessi, M.C., Ardissone, J.P., Heim, M. & Vague, P. (1989) Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients: relations with plasma insulin. Thrombosis and Haemostasis, 61, 370-373.
20. Juhan-Vague, Y., Thompson, S.G. & Jespersen, J., on behalf of the ECAT Angina Pectoris Study Group (1993) Involvement of the hemostatic system in the insulin resistance syndrome: a study of 1500 patients with angina pectoris. Arteriosclerosis and Thrombosis, 13, 1865-1873.
21. Kluft, C., Brakman, P. & Veldhuyzen-Stolk, E.C. (1976) Screening of librinolytic activity in plasma euglobulin fractions on the fibrin plate. Progress in Chemical Fibrinolysis, Vol. 2 (ed. by J. F. Davidson, M. M. Samama and P. C. Desnooyers), pp. 57-65. Raven Press, New York.
22. Kluft, C., Jie, A.H.H. & Lowe, G.D.O. (1986) Association between postoperative hyper-response in t-PA inhibition and deep vein thrombosis. Thrombosis and Haemostasis, 56, 107.
23. Korninger, C., Speizer, W., Wojta, J. & Binder, B.R. (1986) Sandwich ELISA for t-PA antigen employing a monoclonal antibody. Thrombosis Research, 41, 527-535.
24. Lytle, B.W., Loop, F.D., Cosgrove, D.M., Ratliff, N.B. Easley, K. & Taylor, P.C. (1985) Long-term (5-12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. Journal of Thoracic and Cardiovascular Surgery, 89, 248-258.
25. Moor, E., Hamsten, A., Blombäck, M., Herzfeld, Y., Wiman, B. & Ryders, L. (1994) Haemostatic factors and inhibitors and coronary artery bypass grafting: preoperative alterations and relations to graft occlusion. Thrombosis and Haemostasis, 72, 335-342.
26. Nilsson, I.M., Ljungner, H. & Tengborn, L. (1985) Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentraction of plasminogen activator or increased concentration of plasminogen activator inhibitor. British Medical Journal, 290, 1453-1455.
27. Páramo, J.A., Alfaro, M.J. & Rocha, E. (1985a) Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast acting inhibitor: relationship to deep venous thrombosis and influence of prophylaxis. Thrombosis and Haemostasis, 54, 713-716.
28. Páramo, J.A., Colucci, M., Collen, D. & Van de Werf, F. (1985b) Plasminogen activator inhibitor in the blood of patients with coronary artery disease. British Medical Journal, 291, 573-574.
29. Rifón, J., Páramo, J.A., Prósper, F., Collados, M.T., Sarrá, J. & Rocha, E. (1994) Thrombin-antithrombin complexes and prothrombin fragment 1+2 in aorto-coronary bypass surgery: relation to graft occlusion. Hematologic Pathology, 8, 35-42.
30. Rocha, E., Alfaro. M.J., Páramo, J.A. & Cañadell, J.M. (1988) Preoperative identification of patients at high risk of deep venous thrombosis despite prophylaxis in total hip replacement. Thrombosis and Haemostasis, 59, 93-95.
31. Rocha, E. & Pãramo, J.A. (1994) The relationships between impaired fibrinolysis and coronary heart disease: a role for PAI-1. Fibrinolysis, 8, 294-303.
32. Schneider, D.J., Nordt, T.K. & Sobel, B.E. (1993) Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes, 42, 1-7.
33. Schneiderman, J., Sawdey, M.S., Keeton, M.R., Bordin, G.M., Bernstein, E.F., Dilley, R.B. & Loskutoff, D. (1992) Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proceedings of the National Academy of Sciences of the United States of America, 89, 6998-7002.
34. Stalder, M., Hauert, J., Kruithof, E.K.O. & Bachmann, F. (1985) Release of vascular plasminogen activator (v-PA) after venous stasis: electrophoretic-zymographic analysis of free and complexed v-PA. British Journal of Haematology, 61, 69-176.
35. Thompson, S.G. & van de Loo, J.C.W. (1993) ECAT Angina Pectoris Study. Baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. European Heart Journal, 14, 8-17.